|
US6025154A
(en)
|
1995-06-06 |
2000-02-15 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human G-protein chemokine receptor HDGNR10
|
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
EP0962467A4
(en)
|
1996-09-26 |
2002-10-30 |
Chugai Pharmaceutical Co Ltd |
Antibody against human parathormone related peptides
|
|
SE9801098D0
(sv)
*
|
1998-03-30 |
1998-03-30 |
Astra Pharma Prod |
Receptors
|
|
AU3962099A
(en)
*
|
1998-05-07 |
1999-11-23 |
William Douglas Mckee |
Valve assembly
|
|
US6171590B1
(en)
|
1998-09-30 |
2001-01-09 |
Corixa Corporation |
Chemokine receptor peptide for inducing an immune response
|
|
WO2000028028A1
(en)
*
|
1998-11-06 |
2000-05-18 |
Millennium Pharmaceuticals, Inc. |
G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof
|
|
US6329159B1
(en)
*
|
1999-03-11 |
2001-12-11 |
Millennium Pharmaceuticals, Inc. |
Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
|
|
US6358697B2
(en)
|
1999-04-21 |
2002-03-19 |
Children's Hospital Medical Center |
Intracellular pharmaceutical targeting
|
|
JP2003506042A
(ja)
|
1999-08-03 |
2003-02-18 |
ミレニアム ファーマシューティカルズ インク． |
セクレチン様ファミリーの新規ｇｐｃｒ様分子１５５７１及びその使用
|
|
EP2261256A3
(en)
*
|
1999-11-24 |
2011-03-02 |
Schering Corporation |
Methods of inhibiting metastasis
|
|
US6949243B1
(en)
|
1999-11-24 |
2005-09-27 |
Schering Corporation |
Methods of inhibiting metastasis
|
|
AU2001249546A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Corixa Corporation |
Methods for treating disease with antibodies to cxcr3
|
|
US8029793B2
(en)
|
2000-04-28 |
2011-10-04 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for inhibiting cell proliferation
|
|
US7052676B2
(en)
|
2000-09-26 |
2006-05-30 |
The Regents Of The University Of Michigan |
Methods for inhibition of HIV replication using a small molecule inhibitor
|
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
|
AU2002316674B2
(en)
*
|
2001-07-12 |
2007-09-13 |
The Regents Of The University Of California |
CXCL10 treatment of secondary tissue degeneration
|
|
US7442512B2
(en)
|
2001-11-30 |
2008-10-28 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7871619B2
(en)
|
2001-11-30 |
2011-01-18 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7253007B2
(en)
|
2001-11-30 |
2007-08-07 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7413866B2
(en)
|
2001-11-30 |
2008-08-19 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7393934B2
(en)
|
2001-12-21 |
2008-07-01 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor (CCR5) HDGNR10
|
|
EP1491209A4
(en)
*
|
2002-02-28 |
2006-05-17 |
Kyowa Hakko Kogyo Kk |
MEANS FOR DIAGNOSIS AND TREATMENT OF INTERSTITIAL PNEUMONIA
|
|
JPWO2003082335A1
(ja)
*
|
2002-04-03 |
2005-07-28 |
住友製薬株式会社 |
新規血糖調節薬及びそのスクリーニング方法
|
|
NZ566263A
(en)
|
2002-05-24 |
2009-09-25 |
Millennium Pharm Inc |
CCR9 inhibitors and methods of use thereof
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
KR100874292B1
(ko)
|
2002-11-18 |
2008-12-18 |
케모센트릭스 |
아릴 술폰아마이드
|
|
US7741519B2
(en)
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
|
US7227035B2
(en)
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
KR101061352B1
(ko)
|
2002-12-20 |
2011-08-31 |
케모센트릭스 |
인간 종양-발현된 ｃｃｘｃｋｒ2의 저해물질
|
|
US7834155B2
(en)
|
2003-07-21 |
2010-11-16 |
Immunogen Inc. |
CA6 antigen-specific cytotoxic conjugate and methods of using the same
|
|
WO2005030793A2
(en)
|
2003-09-24 |
2005-04-07 |
Millennium Pharmaceuticals, Inc. |
Antibodies which bind human cxcr3
|
|
EP1723970A4
(en)
*
|
2004-03-09 |
2009-08-12 |
Univ Kyoto |
MEDICAL COMPOSITION WITH CXCR3 INHIBITOR
|
|
EP1723178A4
(en)
|
2004-03-12 |
2007-12-12 |
Human Genome Sciences Inc |
HUMAN G-PROTEIN CHEMOKIN RECEPTOR (CCR5) HDGNR10
|
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
ES2434852T3
(es)
|
2005-04-21 |
2013-12-17 |
Chemocentryx, Inc. |
Anticuerpos que se unen a CCX-CKR2
|
|
EP2004675A1
(en)
|
2006-03-16 |
2008-12-24 |
Protagonists Ltd. |
Combination of cytokine and cytokine receptor for altering immune system functioning
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
JP5371780B2
(ja)
*
|
2007-02-01 |
2013-12-18 |
テバ バイオファーマシューティカルズ ユーエスエー インコーポレーティッド |
Ｃｘｃｒ３に対するヒト化抗体
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
JP5306344B2
(ja)
|
2007-07-12 |
2013-10-02 |
ケモセントリックス， インコーポレイテッド |
炎症の治療のためのｃｃｒ２モジュレーターとしての縮合ヘテロアリールピリジルおよびフェニルベンゼンスルホンアミド
|
|
WO2013109974A2
(en)
*
|
2012-01-20 |
2013-07-25 |
Genzyme Corporation |
Anti-cxcr3 antibodies
|
|
HK1212628A1
(zh)
*
|
2012-06-27 |
2016-06-17 |
吉安特科技公司 |
用於抑制炎症的抗-cxcl9、抗-cxcl10、抗-cxcl11、抗-cxcl13、抗-cxcr3和抗-cxcr5试剂
|
|
US9681647B2
(en)
|
2012-07-05 |
2017-06-20 |
Cornell University |
Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using
|
|
WO2014186842A1
(en)
*
|
2013-05-22 |
2014-11-27 |
Monash University |
Antibodies and uses thereof
|
|
RU2765737C2
(ru)
|
2016-11-23 |
2022-02-02 |
Хемоцентрикс, Инк. |
Способ лечения фокально-сегментарного гломерулосклероза
|
|
WO2018106945A1
(en)
|
2016-12-07 |
2018-06-14 |
Progenity Inc. |
Gastrointestinal tract detection methods, devices and systems
|
|
EP3554541B1
(en)
|
2016-12-14 |
2023-06-07 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
|
RU2020113612A
(ru)
|
2017-10-11 |
2021-11-12 |
Хемоцентрикс, Инк. |
Лечение фокально-сегментарного гломерулосклероза антагонистами ccr2
|
|
EP3883635A1
(en)
|
2018-11-19 |
2021-09-29 |
Progenity, Inc. |
Methods and devices for treating a disease with biotherapeutics
|
|
CN115666704B
(zh)
|
2019-12-13 |
2025-09-26 |
比特比德科有限责任公司 |
用于将治疗剂递送至胃肠道的可摄取装置
|
|
EP4277924A2
(en)
*
|
2021-01-12 |
2023-11-22 |
Charité - Universitätsmedizin Berlin |
A cxcr3+ cell or cell preparation for use in cancer treatment
|
|
WO2025185738A1
(zh)
*
|
2024-03-08 |
2025-09-12 |
演生潮(北京)生物科技有限公司 |
靶向cxcr3的抗原结合蛋白及其应用
|